Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2026-05-24 @ 10:10 PM
Study NCT ID:
NCT01023035
Status:
COMPLETED
Last Update Posted:
2021-02-08
First Post:
2009-11-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C, Chronic | View |
Keywords: